Respiratory tract infections of viral origin in immunocompetent patients

Clinical Pulmonary Medicine

Volumn 6, Issue 1, 1999, Pages 9-17

  Rabella, Núria ^a   Prats, Guillem ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b Hospital Sta Creu I St Pau   (Spain)

Author keywords

Adults; Children; Infection; Respiratory; Viruses

Indexed keywords

ACICLOVIR; AMANTADINE; CHICKENPOX VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; RIBAVIRIN; RIMANTADINE;

ADENOVIRUS; BRAIN TOXICITY; CLINICAL FEATURE; CORONAVIRUS; ENTEROVIRUS; GASTROINTESTINAL TOXICITY; HANTAVIRUS; HUMAN; INFLUENZA VIRUS; LOWER RESPIRATORY TRACT INFECTION; ORAL DRUG ADMINISTRATION; PARAINFLUENZA VIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; SEASONAL VARIATION; SUPERINFECTION; UPPER RESPIRATORY TRACT INFECTION; VIRUS DIAGNOSIS; VIRUS INFECTION;

EID: 0033054781     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-199901000-00002     Document Type: Review

References (37)

1. Couch RB. Respiratory diseases. In: Galasso GJ, Withley RJ, Merigan TC, editors. Antiviral agents and viral disease of man. New York: Raven Press, Ltd, 1990:327-72.
2. Denny FW Jr. The clinical impact of human respiratory virus infections. Am Respir Crit Care Med 1995;152:S4-S12.
3. Drews AL, Atmar RL, Glezen WP, Baxter BD, Piedra PA, Greenberg SB. Dual respiratory virus infections. Clin Infect Dis 1997;25:1421-9.
4. Teichtahl H, Buckmaster N, Pertnikovs E. The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest 1997;112:591-6.
5. McNamara MJ, Phillips IA, Williams OB. Viral and Mycoplasma pneumoniae infections in exacerbations of chronic lung disease. Am Rev Respir Dis 1969;100:19-24.
6. Bakaletz LO. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol 1995;3:110-4.
7. Mainous AG, Hueston WJ, Clarck JR. Antibiotics and upper respiratory infection: do some folks think there is a cure for the common cold? J Fam Pract 1996;42:357-61.
8. Hamory BH, Sande MA, Sydnor A Jr, et al. Etiology and antimicrobial therapy of acute maxillary sinusitis. J Infect Dis 1979;139:197-202.
9. Henderson FW, Collier AM, Sanyal MA, et al. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N Engl J Med 1982;306: 1377-83.
10. Chonmaitree T, Howie VM, Truant AL. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 1986;77:698-702.
11. Cherry JD. Pharyngoconjunctival fever. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Vol. I. Philadelphia: W.B. Saunders Co, 1998:158-62.
12. Cherry JD. Croup (laryngitis, laryngotracheitis, spasmodic croup, laryngotracheobronchitis, bacterial tracheitis, and laryngotracheobronchopneumonitis). In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Vol. 1. Philadelphia: W.B. Saunders Co, 1998:228-41.
13. Edwards G. Acute bronchitis: aetiology, diagnosis, and management. BMJ 1966;1:963-6.
14. Hall CB, Hall WJ. Bronchiolitis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. Vol. 1. New York: Churchill Livingstone Inc, 1995:612-7.
15. Dowling HF, Lefkowitz LB Jr. Clinical syndromes in adults caused by respiratory viruses. Am Rev Respir Dis 1963;88:61-72.
16. Greenberg SB. Viral pneumonia. Infect Dis Clin North Am 1991;5:603-21.
17. Rello J, Quintana E, Ausina V, Alvar N, Prats G. A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993;103:232-5.
18. Gwaltney JM Jr. Rhinoviruses. In: Evans AS, editor. Viral infections of humans. Epidemiology and control. Plenum Medical Book Co, New York, 1989:593-615.
19. Tyrrell DAJ. Rhinoviruses and coronaviruses. Virological aspects of their role in causing colds in man. Eur J Respir Dis 1983;128:332-5.
20. Chonmaitree T, Mann L. Respiratory infections. In: Rotbart HA, editor. Human enterovirus infections. Washington, DC: ASM Press, 1995:255-70.
21. Cherry JD. Enteroviruses: coxsackieviruses, echoviruses, and polioviruses. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Vol II. Philadelphia: W.B. Saunders Co, 1998:1787-839.
22. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Vol. II. Philadelphia: W.B. Saunders Co, 1998:2084-111.
23. Chanock RM, Bell JA, Parrott RH. Natural history of parainfluenza infection. Perspectives in Virology 1961;2:126-39.
24. Wenzel RP, McCormick DP, Beam NE. Parainfluenza pneumonia in adults. JAMA 1972; 221:294-5.
25. Cherry JD. Adenoviruses. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Vol. II. Philadelphia: W.B. Saunders Co, 1998:1666-84.
26. Hilleman MR. Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci 1957;67:262-72.
27. Stuart-Harris CH, Schild GC, editors. Influenza. The viruses and the disease. London: Edward Arnold Publishers, 1976.
28. Khan AS, Khabbaz RF, Armstrong LR, et al. Hantavirus pulmonary syndrome: the first 100 US cases. J Infect Dis 1996;173:1297-303.
29. Greenberg SB, Krilov LR. Laboratory diagnosis of viral respiratory disease. In: Drew WL, Rubin SJ, editors. Cumulative techniques and procedures in clinical microbiology [manual]. Cumitech 21. Washington, DC: American Society for Microbiology, March 1986.
30. Ieven M, Goossens H. Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory. Clin Microbiol Rev 1997;10:242-56.
31. Couch RB, Jackson GG. Antiviral agents in influenza: summary of influenza workshop VIII. J Infect Dis 1976;134:516-27.
32. Sidwell RW. Ribavirin: in vitro antiviral activity. In: Smith RA, Kirkpatrick W, editors. Ribavirin: a broad spectrum antiviral agent. New York: Academic Press, 1980:23-42.
33. Committee on Infectious Diseases, American Academy of Pediatrics. Use of ribavirin in the treatment of respiratory syncytial virus infection. In: Peter G, editor. Report of the Committee on Infectious Diseases. 23rd ed. Elk Grove Village, IL: American Academy of Pediatrics, 1994:570-4.
34. CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996; 45:1-24.
35. Chaloner-Larsson G, Contreras G, Furesz J, et al. Immunization of Canadian armed forces personnel with live types 4 and 7 adenovirus vaccines. Can J Pub Health 1986;77:367-70.
36. The PREVENT Study Group. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997;99:93-9.
37. CDC. Licensure of varicella virus vaccine, live. MMWR 1995;44:264.